Document is current
Any future updates will be listed below
-
Authors
Kawai, Hideki https://orcid.org/0000-0003-2924-3615
Motoyama, Sadako
Sarai, Masayoshi
Sato, Yoshihiro
Matsuyama, Takahiro
Matsumoto, Ryota
Takahashi, Hiroshi
Katagata, Akio
Kataoka, Yumi
Ida, Yoshihiro
Muramatsu, Takashi
Ohno, Yoshiharu
Ozaki, Yukio
Toyama, Hiroshi
Narula, Jagat
Izawa, Hideo
-
Funding
Funding for this research was provided by:
Canon Medical Systems Corporation
Bayer Yakuhin
Daiichi-Sankyo
Dainippon Sumitomo Pharma
Kowa Company
Ono Pharmaceutical
Otsuka Pharmaceutical
Takeda Pharmaceutical Company
FUJIFILM Toyama Chemical
- License Information
-
More Information
Article History
Received: 13 January 2023
Revised: 30 May 2023
Accepted: 25 June 2023
First Online: 6 September 2023
Declarations
:
: The Scientific guarantor is Hideki Kawai.
: Yoshiharu Ohno and Hiroshi Toyama have received research grants from Canon Medical Systems. Hideo Izawa has received grant support through his institution from Bayer, Daiichi-Sankyo, Dainihon-Sumitomo, Kowa, Ono, Otsuka, Takeda, and Fuji Film Toyama Kagaku, and honoraria for lectures from Boehringer Ingelheim, Daiichi-Sankyo, Novartis, and Otsuka Corporation. The remaining authors have nothing to disclose.
: One of the authors (Hiroshi Takahashi) has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.An opt-out method on our department’s website was used to obtain consent for this study.
: Institutional Review Board approval was obtained.The study protocol was approved by the Institutional Review Board and ethics committees of the Fujita Health University.
: None.
: • Retrospective• diagnostic study• performed at one institution
